MAPT and amyloidosis: More recently, in a cross-sectional design examining cognitively normal (CN) older adult participants, Rodriguez-Vieitez and colleagues explored the relationship between cMD and AD pathological hallmarks measured by amyloid and tau PET imaging, and demonstrated that cMD was positively associated with tau but not amyloid burden15.